FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		1 Months Ended	3 Months Ended			6 Months Ended
	Mar. 02, 2021 USD ($)	Jan. 31, 2021 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 $ / shares	Apr. 06, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($)	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Change in fair value of financial instruments and other			$ 4,229		$ 0	$ 9,612	$ 100
Investment in DeFloria			10,700			10,700				$ 0
Debt interest rate conversion feature			836			836				1,320
Purchase option	$ 8,000	$ 8,000
Purchase option, term		5 years
Extension, term		2 years
Percentage of outstanding shares		10.00%
Warrants expiration period													60 days
Gain on change in fair value of purchase option			57	$ (243)	$ 0		$ 100
Stanley Brothers USA Holdings Purchase Option			2,057			2,057				2,300
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage									50.00%
British American Tobacco | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units ownership percentage									100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity method ownership percentage									50.00%
DeFloria, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units (in shares) | shares									400,000
Change in fair value of financial instruments and other			0			0
Investment in DeFloria			10,700			10,700
DeFloria, LLC | Class A Common Stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding (in shares) | shares									865,052
Warrants exercise price (in USD per share) | $ / shares									$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units (in shares) | shares									200,000
Capital contributed									$ 10,000
DeFloria, LLC | AJNA Biosciences
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred units (in shares) | shares									400,000
Debt Conversion Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments			(4,066)			(10,361)
Derivatives and other liabilities, noncurrent			2,815			2,815				12,995
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in DeFloria			10,700			10,700
Debt interest rate conversion feature			836			836				1,320
Debt Interest Rate Conversion Feature
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unrealized gain (loss) on hedging instruments			$ 106			$ (506)
BAT Group
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible ownership percentage			19.90%			19.90%					19.90%	19.90%
Conversion price (in CAD per share) | $ / shares								$ 2.00				$ 2.00
BAT Group | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage											5.00%	5.00%
BAT Group | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Accrued interest rate, percentage											1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Principal Amount			$ 58,677			$ 58,677				$ 56,080	$ 56,800	$ 75.3